SBIR/STTR Research Award

SUBSTANCE P-SPECIFIC CONDUCTING POLYMER ELECTRODE

Award identifier a3335d33c63882738025ede3f79a5ee698d89945a1bb5aa58c617d46587efb5cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,793

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Fractal Systems, Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION: Neuroactive peptides are the key players in a variety of human responses to pain, stress, hemorrhage, transfusion, orthostasis and anoxia, and are affecting the immune system The concentration of a specific neuropeptide in a certain system of the body can provide us with critical information on the state of health or disease. At present, there are no neuropeptide-specific electrodes available. We propose to develop an electrode for specific sensing of Substance P, a neuropeptide involved in the endogenous pain control in the central nervous system. We will be utilizing a novel approach of electrochemical registration of the conductivity changes, occurring in specifically designed conductive polymer matrix upon cooperative interaction of the immobilized on the matrix antibodies with selected neuropeptide. Specificity of such electrode can be designed by choosing the specificity of immobilized antibody. Phase I will be dedicated to the development and calibration of Substance P specific electrode in vitro. Phase I will be dedicated to miniaturization of the electrode and in vivo applications. An array of such electrodes with designed specificity will be able to detect several peptide neurotransmitters from the same site. PROPOSED COMMERCIAL APPLICATION: Electrodes, developed based on our approach, will represent a significant advance in the detection of peptide neurotransmitters, and will be a far better alternative to the immunoassays, which are currently used. Using an array of such electrodes with different specificity, it will be possible to detect several peptide neurotransmitters in vivo and from the same site, which will allow to study the interactive actions of neuropeptides on the neuroendocrine system.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.